These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

391 related items for PubMed ID: 21768514

  • 21. Lathyrol and epoxylathyrol derivatives: Modulation of Cdr1p and Mdr1p drug-efflux transporters of Candida albicans in Saccharomyces cerevisiae model.
    Mónico A, Nim S, Duarte N, Rawal MK, Prasad R, Di Pietro A, Ferreira MU.
    Bioorg Med Chem; 2017 Jul 01; 25(13):3278-3284. PubMed ID: 28479022
    [Abstract] [Full Text] [Related]

  • 22. Histatin-5 induces the reversal of Pdr5p mediated fluconazole resistance in Saccharomyces cerevisae.
    da Rocha Curvelo JA, Reis de Sá LF, Moraes DC, Soares RM, Ferreira-Pereira A.
    J Mycol Med; 2018 Mar 01; 28(1):137-142. PubMed ID: 29217144
    [Abstract] [Full Text] [Related]

  • 23. Mechanism of action of tetrandrine, a natural inhibitor of Candida albicans drug efflux pumps.
    Zhang H, Gao A, Li F, Zhang G, Ho HI, Liao W.
    Yakugaku Zasshi; 2009 May 01; 129(5):623-30. PubMed ID: 19420894
    [Abstract] [Full Text] [Related]

  • 24. Farnesol-induced apoptosis in Candida albicans is mediated by Cdr1-p extrusion and depletion of intracellular glutathione.
    Zhu J, Krom BP, Sanglard D, Intapa C, Dawson CC, Peters BM, Shirtliff ME, Jabra-Rizk MA.
    PLoS One; 2011 May 01; 6(12):e28830. PubMed ID: 22205973
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transporters.
    Nakamura K, Niimi M, Niimi K, Holmes AR, Yates JE, Decottignies A, Monk BC, Goffeau A, Cannon RD.
    Antimicrob Agents Chemother; 2001 Dec 01; 45(12):3366-74. PubMed ID: 11709310
    [Abstract] [Full Text] [Related]

  • 27. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
    Tsao S, Rahkhoodaee F, Raymond M.
    Antimicrob Agents Chemother; 2009 Apr 01; 53(4):1344-52. PubMed ID: 19223631
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Synergistic interactions between β-lapachone and fluconazole in the inhibition of CaCdr2p and CaMdr1p in Candida albicans.
    Moraes DC, Reis de Sá LF, Domingos LTS, Pinto MDCFR, Soares RMA, Ferreira-Pereira A.
    Rev Iberoam Micol; 2020 Apr 01; 37(3-4):104-106. PubMed ID: 33229297
    [Abstract] [Full Text] [Related]

  • 31. Rationally designed transmembrane peptide mimics of the multidrug transporter protein Cdr1 act as antagonists to selectively block drug efflux and chemosensitize azole-resistant clinical isolates of Candida albicans.
    Maurya IK, Thota CK, Verma SD, Sharma J, Rawal MK, Ravikumar B, Sen S, Chauhan N, Lynn AM, Chauhan VS, Prasad R.
    J Biol Chem; 2013 Jun 07; 288(23):16775-16787. PubMed ID: 23592791
    [Abstract] [Full Text] [Related]

  • 32. In vitro interactions between farnesol and fluconazole, amphotericin B or micafungin against Candida albicans biofilms.
    Katragkou A, McCarthy M, Alexander EL, Antachopoulos C, Meletiadis J, Jabra-Rizk MA, Petraitis V, Roilides E, Walsh TJ.
    J Antimicrob Chemother; 2015 Feb 07; 70(2):470-8. PubMed ID: 25288679
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Evaluation of Jatrophane Esters from Euphorbia spp. as Modulators of Candida albicans Multidrug Transporters.
    Esposito M, Nim S, Nothias LF, Gallard JF, Rawal MK, Costa J, Roussi F, Prasad R, Di Pietro A, Paolini J, Litaudon M.
    J Nat Prod; 2017 Feb 24; 80(2):479-487. PubMed ID: 28106996
    [Abstract] [Full Text] [Related]

  • 37. Chimeras of Candida albicans Cdr1p and Cdr2p reveal features of pleiotropic drug resistance transporter structure and function.
    Tanabe K, Lamping E, Nagi M, Okawada A, Holmes AR, Miyazaki Y, Cannon RD, Monk BC, Niimi M.
    Mol Microbiol; 2011 Oct 24; 82(2):416-33. PubMed ID: 21895791
    [Abstract] [Full Text] [Related]

  • 38. Inhibitor-Resistant Mutants Give Important Insights into Candida albicans ABC Transporter Cdr1 Substrate Specificity and Help Elucidate Efflux Pump Inhibition.
    Niimi M, Niimi K, Tanabe K, Cannon RD, Lamping E.
    Antimicrob Agents Chemother; 2022 Jan 18; 66(1):e0174821. PubMed ID: 34780272
    [Abstract] [Full Text] [Related]

  • 39. Activity of Isavuconazole and Other Azoles against Candida Clinical Isolates and Yeast Model Systems with Known Azole Resistance Mechanisms.
    Sanglard D, Coste AT.
    Antimicrob Agents Chemother; 2016 Jan 18; 60(1):229-38. PubMed ID: 26482310
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 20.